socalTECH

MAY 9, 2013

San Diego-based biopharmaceuticals developer Receptos is trading flat after its initial public offering, after pricing last night at $14.00 The developer of biopharmaceuticals for treating immune and metabolic diseases priced at the low end of its estimated IPO range, which was $14.00 READ MORE>>.

San Diego 159

San Diego Pricing Venture Capital Acquisition 159

Xconomy

DECEMBER 10, 2018

ASG Technologies, the Florida-based software company backed by activist hedge fund Elliott Management, has upped its offer for San Diego’s Mitek Systems to $11.50 The stock price of Mitek (NASDAQ:MITK) rose nearly 9 percent on the news, closing at $9.75. per share from $10 apiece. That’s according to a Nov.

Pricing 43

Pricing Acquisition News Software 43

socalTECH

NOVEMBER 27, 2017

San Diego-based Odonate Therapeutics , a startup that says it is hoping to develop chemotherapy drugs, is looking to raised $182.5M The company has set its estimated IPO price range at between $24.00 in an IPO on the NASDAQ Global Select Market. and $27.00 The company's IPO is being underwritten by Goldman Sachs & Co.,

San Diego 113

San Diego Pricing Capital Funding 113

socalTECH

FEBRUARY 20, 2018

San Diego-based Qualcomm has upped its offer for fellow semiconductor developer NXP Semiconductor N.V. saying that it has increased its offer to $127.50 in cash per share for NXP. Qualcomm had previously offered $110.00 per share in cash to acquire NXP. The bid raises Qualcommm's offer for NXP to a total of $44.0 READ MORE>>.

San Diego 113

San Diego Pricing Capital Funding 113

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M Anaptys priced its IPO on Wednesday night at $15.00 AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

OCTOBER 7, 2009

San Diego-based Gen-Probe said Tuesday that it has signed a definitive agreement to acquire Prodesse, a provider of molecular testing for influenza and other infection diseases. The deal is worth $60M in cash, with provision to increase the price to $85M on meeting specific financial and regulatory milestones.

San Diego 140

San Diego Acquisition Pricing Funding 140

socalTECH

MAY 20, 2010

per share, after pricing below its initial offering range on Wednesday evening, and had traded as high as $15.26 The firm, which is headed by Zorik Gordon, was venture backed by VantagePoint Venture Partners, Rho Ventures, Galleon Group, European Founders Fund, and others. The firm sold 4,166,667 shares of stock at $13.00 READ MORE>>.

ReachLocal 157

ReachLocal Woodland Hills Thousand Oaks NewEgg 157

socalTECH

JUNE 30, 2010

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M. Solomon Company in the deal.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140

TechCrunch LA

MARCH 22, 2018

Our research revealed a saturation level causing unprecedented challenges, starting with exorbitant housing prices and runaway operating costs that accelerate a startup’s “burn rate”—its monthly spending. Suster has also noted for years that the region produces more technology doctorates than any other geography in the United States.

Southern California 224

Southern California Dollar Shave Club SoCal Develop 224

socalTECH

FEBRUARY 8, 2012

The board of directors of San Diego-based Illumina , the life sciences tools and analysis systems firm, said last night that it has rejected the unsolicited offer from Roche. Illumina also pointed out that Roche's bid is below the current trading price for its stock, which was most recently trading around $51.80

San Diego 124

San Diego Pricing Research Tool 124

Xconomy

OCTOBER 27, 2016

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says. They also queried 15 VC firms.

Venture Capital 40

Venture Capital Pricing Invest Report 40

Xconomy

MARCH 20, 2017

Japan’s Murata Manufacturing has acquired Arctic Sand Technologies of Burlington, MA, and plans to combine Arctic Sand’s low-power semiconductor technology with its San Diego-based subsidiary, Peregrine Semiconductor. The purchase price was $68 million, according to a Peregrine spokeswoman.

San Diego 63

San Diego Mobile Pricing Technology 63

Xconomy

AUGUST 16, 2017

Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. Dry powder levels in North American and European PE funds reached new heights of $738.7 As of Aug. 1, private equity firms in North America and Europe had secured $212.6

Equity 69

Equity Pricing Acquisition Report 69

Xconomy

JUNE 3, 2016

Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. But billions of dollars in acquisitions will be left by the side of the road. Bad FDA news for Teva Pharmaceutical and AstraZeneca also threw outsized acquisitions into question. Teva nabbed deutetrabenazine in its $3.2

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service. The deal also reflects Petco’s expanding interests in technology following the company’s $4.6-billion

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

SEPTEMBER 7, 2016

San Diego-based Retrophin said that its drug, sparsentan, outperformed another drug sometimes used to manage a rare kidney disease, called focal segmental glomerulosclerosis (FSGS), in a Phase 2 clinical trial. He licensed the drug from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) in March 2012. to $30 apiece.

San Diego 40

San Diego Pricing Study Journal 40

Xconomy

DECEMBER 22, 2016

There are many benefits to obtaining venture capital financing, including: immediate access to a significant amount of capital; potential access to additional funds held in reserve by the investors for future rounds of financing; access to the investors’ expertise, experience and network; immediate credibility in.

Pricing 40

Pricing Venture Capital Capital Networking 40

Xconomy

OCTOBER 7, 2016

military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. PRICE FIGHTS. —The U.S.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

JULY 1, 2016

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

AUGUST 16, 2016

The industry can only go so far with growth through hyper-inflated pricing and mega-M&As. At some point pharma has to figure out how to make more drugs more efficiently, or face major dislocations like business-destroying price controls. pension funds) with little appetite for experimentation with new managers and more funds.

Product 40

Product Journal Venture Capital Demand 40

Xconomy

JANUARY 4, 2019

Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches). You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69

Pricing Email Networking Silver Lake 69

socalTECH

JUNE 3, 2013

One of the companies that has taken advantage of that is OneRoof Energy (www.oneroofenergy.com), a San Diego company headed by David Field. But, since it''s priced against the local utility, that investors can get a 9, 10, 11, or 12 percent yield. To date, we''ve raise money on a tax equity fund from U.S. Can you explain?

Equity 234

Equity Invest Marketing Product 234

Xconomy

OCTOBER 3, 2018

Share prices for the two Silicon Valley companies spiked in after-hours trading following the announcement Wednesday that both their boards approved the all-stock deal.

Platform 93

Platform Software Review Web Pricing 93

Xconomy

JANUARY 26, 2018

The United States has a new Health and Human Services chief who is expected to weigh in on the country’s drug-pricing debate. Xconomy examined its owners’ justification for the price, and why a drug-value watchdog pushed back hard.

Pricing 49

Pricing News Services San Diego 49

socalTECH

SEPTEMBER 29, 2011

We want to create the right mix of the types of activities, price points, and make sure we have high quality content and high quality activities. Also, we've got a few entrepreneurs, including Kevin Chou, who is at Kabam up north, and has raised $150M in funding, and Alex Bard, who was at Goowy, which he sold to AOL.

Startup 271

Startup CTO Coach Activity Software Review 271

Xconomy

SEPTEMBER 1, 2017

billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9

Pricing 74

Pricing Ideas San Diego Study 74

Xconomy

JUNE 28, 2016

First, let’s cover basic components you’d see in a letter of intent for a startup M&A deal: — The sticker price : The cost to acquire the target. — Price adjustments : Possible reductions (due to debt or liabilities exceeding assets) or increases (based on financial performance).

Startup 57

Startup Pricing Sales Summary 57

Xconomy

JULY 29, 2016

But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. CARB-X will also run four accelerators—in San Francisco, Cambridge, MA, and two in the U.K.

Startup 40

Startup Study News Report 40

Xconomy

JULY 19, 2016

In 2015, Cybersecurity startups saw 332 funding deals with investments hitting the highest ever at $3.8 New funds have been raised dedicated to this segment. In an ideal world, and from the perspective of a venture investor, this would absolutely be the case. billion (235 percent growth over 5 years).

Symantec 40

Symantec IBM IBM Acquisition 40

socalTECH

APRIL 22, 2010

In California, the three major electrical utilities--PG&E, which covers all of Northern California and pretty far into Central California, Edison in Southern California, and in San Diego PG&E, are all deploying smart meters now. In private equity it's funded on the front end, and it grows from there. READ MORE>>.

Equity 124

Equity San Diego Startup Activity 124

Xconomy

FEBRUARY 16, 2018

There was talk of tackling high drug prices in the budget document, but nothing to give Medicare direct negotiating power with drug companies or allow importation of cheaper drugs from other countries—ideas Trump has embraced on occasion.

Pricing 57

Pricing Ideas Artificial Inteligence San Diego 57

Xconomy

AUGUST 12, 2016

Xconomy spoke with Jacks and CEO and longtime tech entrepreneur Bill Haney about the venture, a cancer immunotherapy startup that is relying on funding from family offices—among them the Disney family—rather than venture firms. In the U.S.,

Google 40

Google Technical Review News Research 40

Xconomy

OCTOBER 27, 2017

The White House and the FDA turned the spotlight on the nation’s opioid crisis. Blockbuster drugs from Alexion and Tesaro gained expanded approvals, but bad earnings news from Celgene and Biogen brought stocks down. Academics in the U.S. and China made progress with the gene editing technology CRISPR.

News 57

News Research Technology San Diego 57

SoCal Delicious

OCTOBER 8, 2012

Venture capitalist and hedge-fund manager Peter Thiel—PayPals co-founder and Facebook s. Prices are soaring in the beachfront communities tech types favor, and rents in these. Prices have gone up dramatically on this beachfront strip. Median single-family home price increase, Jan.-Aug. the entertainment industry.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

SoCal Delicious

MAY 6, 2012

He previously led business development for Affiliate Fuel, leading to its acquisition by Experian in 2005. After the acquisition, MyMiniLife became the common technology platform at Zynga and powers 150M monthly users including games like Cityville, Farmville, and Frontierville. She just spoke at TED EX in San Diego.

Los Angeles 78

Los Angeles Entrepreneur Angel Fractional CTO 78